BFM
NVAX icon

Boothbay Fund Management’s Novavax NVAX Stock Holding History

Boothbay Fund Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-86,500
Closed -$695K – 1664
2024
Q4 		$695K Buy
+86,500
New +$834K 0.02% 759
2024
Q1 		– Sell
-151,600
Closed -$728K – 1830
2023
Q4 		$728K Hold
151,600
– – 0.02% 830
2023
Q3 		$1.1M Buy
151,600
+70,300
+86% +$562K 0.03% 723
2023
Q2 		$604K Buy
+81,300
New +$639K 0.01% 1013
2021
Q4 		– Sell
-7,100
Closed -$1.47M – 2112
2021
Q3 		$1.47M Buy
+7,100
New +$1.56M 0.04% 573
2021
Q2 		– Sell
-78
Closed -$1.41M – 2030
2021
Q1 		$1.41M Buy
+78
New +$15.5K 0.05% 454
2019
Q2 		– Sell
-201
Closed -$222K – 844
2019
Q1 		$222K Buy
+201
New +$6.35K 0.02% 583

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's NVAX Position: Q1 2024 in Review

Boothbay Fund Management sold out of Novavax (NVAX) in Q1 2024, closing a stake of 53,506 shares — an estimated $257K sold.

Boothbay Fund Management first reported a position in NVAX in Q2 2017 and held it in 5 quarters. The position peaked at $724K in Q3 2023. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

  • Boothbay Fund Management reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 53,506 Novavax shares in Q1 2024, an estimated $257K.
  • Boothbay Fund Management first reported a position in Novavax in Q2 2017 and held it in 5 quarters.
  • Boothbay Fund Management's Novavax position peaked at $724K in Q3 2023.
  • 201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.